Company: INV
Filing Date: 2025-04-15
Form Type: S-1
Source: 0001628280-25-017890
Chunk: 36

Company: Innventure, Inc.
Filing Date: 2025-04-15
Form: S-1
Chunk 36
---
 for the use of recycled plastics in food

packaging, as set forth in the “Guidance for Industry - Use of Recycled Plastics in Food Packaging: Chemistry

Considerations (August 2006).” In order for AFX’s products to be used in food grade applications, AFX will be

18

required to partner with customers or third-party co-manufacturers that possess the required food certifications to do

the filling of AFX’s package.

The process of obtaining FDA regulatory approval requires the expenditure of substantial time, of up to one

year, and significant financial resources. If AFX decides to partner with qualified customers or third-party co-

manufacturers to fill AFX’s package, the search for and negotiations required for such relationships would require

significant time, effort, and financial resources to complete, and may not result in a successful production

relationship. All of the above would have an adverse effect on AFX’s business, financial condition, results of

operations and prospects.

Furthermore, changes in regulatory requirements, laws and policies, or evolving interpretations of existing

regulatory requirements, laws and policies, may result in increased compliance costs, delays, capital expenditures

and other financial obligations that could adversely affect AFX’s business, financial condition, results of operations

and prospects.

AFX expects to encounter regulations in most if not all of the countries in which AFX may seek to expand, and

AFX cannot be sure that it will be able to obtain necessary approvals in a timely manner or at all. If AFX’s products

do not meet applicable regulatory requirements in a particular country or at all, then AFX may face reduced market

demand in those countries and AFX’s business, financial condition, results of operations and prospects will be

adversely affected.

The various regulatory schemes applicable to AFX’s products will continue to apply following initial approval.

Monitoring regulatory changes and our ongoing compliance with applicable requirements is time-consuming and

may affect AFX’s business, financial condition, results of operation and prospects. If AFX fails to comply with such

requirements on an ongoing basis, AFX may be subject to fines or other penalties, or may be prevented from selling

its products, and AFX’s business, financial condition, results of operation and prospects may be harmed.

Risks Related to Our Common Stock

The market price of our Common Stock is likely to be highly volatile, and you may lose some or all of your

investment.

The market price of our Common Stock may fluctuate significantly due to